Healthcare -
Biotechnology - NASDAQ - US
$ 32.87
-2.9 %
$ 1.88 B
Market Cap
13.1
P/E
HRMY - COST OF REVENUE
Cost of Revenue HRMY - Harmony Biosciences Holdings, Inc.
121 M
LAST VALUE
47.77%
2 YEAR CAGR
266.24%
5 YEAR CAGR
0.00%
10 YEAR CAGR